Eli Lilly Invests Weight-Loss Profits in AI for Drug Discovery

Eli Lilly, maker of Mounjaro, is deploying its weight-loss drug profits to create an 'App Store' for scientists, collaborating with small biotechs to utilize AI as a tool for drug discovery.